financetom
Business
financetom
/
Business
/
UK's Assura gets preliminary approach from KKR, pension fund
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK's Assura gets preliminary approach from KKR, pension fund
Feb 14, 2025 10:16 AM

Feb 14 (Reuters) - British healthcare real estate

investment trust Assura said on Friday it had received a

preliminary approach from KKR and UK-based pension fund

Universities Superannuation Scheme.

U.S. private equity fund KKR and Universities Superannuation

Scheme, which offers principal pension scheme provided by

educational institutions for their employees, have until March

14 to make a firm offer or walk away.

"Board is currently reviewing the proposal with its

advisers" Assura said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Riot Platforms to Offer $500 Million of Senior Notes Due 2030
Riot Platforms to Offer $500 Million of Senior Notes Due 2030
Dec 9, 2024
07:50 AM EST, 12/09/2024 (MT Newswires) -- Riot Platforms ( RIOT ) said Monday it plans to offer $500 million of convertible senior notes due 2030 in a private offering. The company plans to grant initial purchasers a 3-day option to buy up to an additional $75 million of notes. Net proceeds will be used to buy additional bitcoin and...
Global Advertising Revenue Expected to Exceed $1 Trillion in 2024, GroupM Report Says
Global Advertising Revenue Expected to Exceed $1 Trillion in 2024, GroupM Report Says
Dec 9, 2024
07:50 AM EST, 12/09/2024 (MT Newswires) -- Global advertising revenue is projected to grow 9.5% this year to exceed $1 trillion for the first time and another 7.7% in 2025 to reach $1.1 trillion, according to GroupM's End-of-Year Global Advertising Forecast for 2024 published on Sunday. Alphabet's (GOOG, GOOGL) Google ( GOOG ), Meta Platforms ( META ) , ByteDance,...
Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients
Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients
Dec 9, 2024
On Sunday, Arcellx, Inc. ( ACLX ) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma (RRMM). The data will be presented at the American Society of Hematology (ASH) Annual Meeting and Exposition. Anito-cel is partnered with Kite, a Gilead Science Inc’s company. Also Read: Arcellx’s Lead Asset...
Astrazeneca, Daiichi Sankyo's Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in US
Astrazeneca, Daiichi Sankyo's Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in US
Dec 9, 2024
07:47 AM EST, 12/09/2024 (MT Newswires) -- Astrazeneca ( AZN ) said Monday that the US Food and Drug Administration has granted breakthrough therapy designation for datopotamab deruxtecan for the treatment of locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer in adult patients. The company said the designation is intended to expedite the development and regulatory...
Copyright 2023-2026 - www.financetom.com All Rights Reserved